IART Q1 2022 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$377M+4.6% YoY

Gross Profit

$234M62.1% margin

Operating Income

$46M12.3% margin

Net Income

$33M8.7% margin

EPS (Diluted)

$0.39

QoQ Revenue Growth

-7.1%

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

$30M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$2.1B

Stockholders' Equity

$1.6B

Cash & Equivalents

$407M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$377M	$360M	+4.6%
Gross Profit	$234M	$214M	+9.3%
Operating Income	$46M	$31M	+50.3%
Net Income	$33M	$45M	-27.5%

Revenue Segments

Codman Specialty Surgical

$247M66%

Tissue Technologies

$129M34%

Geographic Segments

UNITED STATES

$263M70%

Asia Pacific

$48M13%

Europe

$44M12%

Rest Of World

$22M6%